EPISODE · Jun 1, 2022
June JAAD: Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis Hidradenitis Suppurativa Foundations
from AAD's Dialogues in Dermatology
Suiting Ao, MD and Wang Fang, MD interviewed by Steven Chen, MD, FAAD
Embed this episode
Ready to play
June JAAD: Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis Hidradenitis Suppurativa Foundations
0:00
0:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
When was this AAD's Dialogues in Dermatology episode published?
This episode was published on June 1, 2022.
Can I download this AAD's Dialogues in Dermatology episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!